$BKYI
BIO KEY INTERNATIONAL INC Stock $bkyi

$bkyi Overview Financials Valuation SEC Filings Company Website

2019 Q1 Form 10-K Financial Statement

#000143774919006258 Filed on April 01, 2019

Income Statement

Concept	2019 Q1	2018 Q1	2018
Revenue	$551.6K	$841.5K	$4.045M
YoY Change	-34.44%	-40.67%	-35.83%
Cost Of Revenue	$604.1K	$1.179M	$4.164M
YoY Change	-48.79%	78.45%	28.44%
Gross Profit	-$52.43K	-$338.0K	-$119.6K
YoY Change	-84.49%	-144.62%	-103.91%
Gross Profit Margin	-9.5%	-40.17%	-2.96%
Selling, General & Admin	$1.377M	$1.462M	$5.334M
YoY Change	-5.8%	-9.77%	-6.03%
% of Gross Profit
Research & Development	$374.1K	$392.2K	$1.415M
YoY Change	-4.6%	-20.53%	-14.73%
% of Gross Profit
Depreciation & Amortization	$19.29K	$21.02K	$84.62K
YoY Change	-8.22%	168.83%	60.54%
% of Gross Profit
Operating Expenses	$1.751M	$1.854M	$6.749M
YoY Change	-5.55%	-12.28%	-8.0%
Operating Profit	$70.00	-$2.192M	$80.00
YoY Change	-100.0%	61.63%	-100.0%
Interest Expense		$0.00
YoY Change
% of Operating Profit
Other Income/Expense, Net	-$1.804M	$6.00	-$6.869M
YoY Change	-30059733.33%	0.0%	-25440674.07%
Pretax Income	-$1.800M	-$2.190M	-$6.870M
YoY Change	-17.81%	61.03%	60.51%
Income Tax			$0.00
% Of Pretax Income
Net Earnings	-$1.804M	-$2.192M	-$6.869M
YoY Change	-17.72%	61.63%	60.66%
Net Earnings / Revenue	-326.95%	-260.5%	-169.83%
Basic Earnings Per Share
Diluted Earnings Per Share	-$1.029M	-$2.235M	-$4.738M
COMMON SHARES
Basic Shares Outstanding	13.99M
Diluted Shares Outstanding

Balance Sheet

Concept	2019 Q1	2018 Q1	2018
SHORT-TERM ASSETS
Cash & Short-Term Investments	$460.0K	$1.300M	$320.0K
YoY Change	-64.62%	12.07%	10.34%
Cash & Equivalents	$459.3K	$1.300M	$320.0K
Short-Term Investments
Other Short-Term Assets	$75.82K	$54.05K	$1.280M
YoY Change	40.3%	-54.16%	-54.12%
Inventory	$980.9K	$899.2K	$1.000M
Prepaid Expenses
Receivables	$740.4K	$305.2K	$1.570M
Other Receivables	$80.00K	$50.00K	$60.00K
Total Short-Term Assets	$3.557M	$5.455M	$4.230M
YoY Change	-34.8%	23.78%	-39.66%
LONG-TERM ASSETS
Property, Plant & Equipment	$152.7K	$193.0K	$150.0K
YoY Change	-20.88%	221.7%	-16.67%
Goodwill
YoY Change
Intangibles	$194.3K	$175.4K
YoY Change	10.76%	21.31%
Long-Term Investments
YoY Change
Other Assets	$310.0K	$370.0K	$330.0K
YoY Change	-16.22%	3600.0%	3200.0%
Total Long-Term Assets	$7.707M	$8.679M	$7.460M
YoY Change	-11.2%	-22.63%	-17.75%
TOTAL ASSETS
Total Short-Term Assets	$3.557M	$5.455M	$4.230M
Total Long-Term Assets	$7.707M	$8.679M	$7.460M
Total Assets	$12.28M	$16.32M	$11.69M
YoY Change	-24.73%	4.45%	-27.3%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$472.6K	$253.0K	$480.0K
YoY Change	86.82%	64.61%	-4.0%
Accrued Expenses	$578.0K	$524.7K	$550.0K
YoY Change	10.16%	38.07%	-20.29%
Deferred Revenue	$333.2K
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$1.655M	$1.522M	$1.230M
YoY Change	8.79%	-6.38%	-47.21%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$420.0K
YoY Change
Total Long-Term Liabilities	$419.2K	$0.00	$0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities	$1.655M	$1.522M	$1.230M
Total Long-Term Liabilities	$419.2K	$0.00	$0.00
Total Liabilities	$1.816M	$1.522M	$1.230M
YoY Change	19.38%	-6.38%	-47.21%
SHAREHOLDERS EQUITY
Retained Earnings	-$76.94M	-$66.84M
YoY Change	15.11%	4.18%
Common Stock	$1.399K	$949.00
YoY Change	47.42%	55.57%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$9.189M	$12.61M	$10.47M
YoY Change
Total Liabilities & Shareholders Equity	$12.28M	$16.32M	$11.69M
YoY Change	-24.73%	4.45%	-27.3%

Cashflow Statement

Concept	2019 Q1	2018 Q1	2018
OPERATING ACTIVITIES
Net Income	-$1.804M	-$2.192M	-$6.869M
YoY Change	-17.72%	61.63%	60.66%
Depreciation, Depletion And Amortization	$19.29K	$21.02K	$84.62K
YoY Change	-8.22%	168.83%	60.54%
Cash From Operating Activities	$160.5K	$1.044M	-$1.613M
YoY Change	-84.62%	792.47%	-34.56%
INVESTING ACTIVITIES
Capital Expenditures	$23.39K	$32.86K	$52.06K
YoY Change	-28.81%	136.5%	-68.65%
Acquisitions
YoY Change
Other Investing Activities	$0.00		-$30.00K
YoY Change			-50.0%
Cash From Investing Activities	-$25.13K	-$32.86K	-$82.46K
YoY Change	-23.52%	136.5%	-63.64%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$1.875M
YoY Change			-6.25%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities			1.731M
YoY Change			-9.82%
NET CHANGE
Cash From Operating Activities	160.5K	1.044M	-1.613M
Cash From Investing Activities	-25.13K	-32.86K	-82.46K
Cash From Financing Activities			1.731M
Net Change In Cash	135.4K	1.011M	35.22K
YoY Change	-86.61%	940.95%	-104.56%
FREE CASH FLOW
Cash From Operating Activities	$160.5K	$1.044M	-$1.613M
Capital Expenditures	$23.39K	$32.86K	$52.06K
Free Cash Flow	$137.1K	$1.011M	-$1.666M
YoY Change	-86.44%	880.89%	-36.71%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
CY2018	bkyi	Accrual Of Unpaid Preferred Stock Dividends AccrualOfUnpaidPreferredStockDividends	198033
CY2017	bkyi	Accrual Of Unpaid Preferred Stock Dividends AccrualOfUnpaidPreferredStockDividends	630408
CY2018Q4	bkyi	Accrued Factoring Fees Current AccruedFactoringFeesCurrent	19000
CY2017Q4	bkyi	Accrued Factoring Fees Current AccruedFactoringFeesCurrent	32357
CY2018	bkyi	Amortization Of Software License Rights AmortizationOfSoftwareLicenseRights	1513237
CY2017	bkyi	Amortization Of Software License Rights AmortizationOfSoftwareLicenseRights	1510051
CY2017	bkyi	Class Of Warrant Or Right Grants In Period ClassOfWarrantOrRightGrantsInPeriod	138889
CY2018	bkyi	Class Of Warrant Or Right Grants In Period ClassOfWarrantOrRightGrantsInPeriod	1035000
CY2018	bkyi	Class Of Warrant Or Right Increase Due To Trigger Of Antidilution Provision Future ClassOfWarrantOrRightIncreaseDueToTriggerOfAntidilutionProvisionFuture	1492848
CY2017	bkyi	Conversion Of A1 Preferred Dividends Payable Amount Converted ConversionOfA1PreferredDividendsPayableAmountConverted	540000
CY2018	bkyi	Conversion Of A1 Preferred Dividends Payable Amount Converted ConversionOfA1PreferredDividendsPayableAmountConverted	356015
CY2018	bkyi	Conversion Of B1 Preferred Dividends Payable Amount Converted ConversionOfB1PreferredDividendsPayableAmountConverted	472424
CY2017Q3	bkyi	Conversion Of Dividends Payable Shares Issued ConversionOfDividendsPayableSharesIssued	150000
CY2018	bkyi	Cumulative Effect Of New Accounting Standard In Period Of Adoption CumulativeEffectOfNewAccountingStandardInPeriodOfAdoption	240017
CY2018	bkyi	Deemed Dividend Down Round Features DeemedDividendDownRoundFeatures
CY2018	bkyi	Effective Income Tax Reconciliation Permanent Differences EffectiveIncomeTaxReconciliationPermanentDifferences
CY2017	bkyi	Effective Income Tax Reconciliation Permanent Differences EffectiveIncomeTaxReconciliationPermanentDifferences
CY2018Q4	bkyi	Factored Accounts Receivable Factored Amount FactoredAccountsReceivableFactoredAmount	164438
CY2018	bkyi	Effective Income Tax Reconciliation Effect Of Net Operating Loss EffectiveIncomeTaxReconciliationEffectOfNetOperatingLoss	-0.21
CY2017	bkyi	Effective Income Tax Reconciliation Effect Of Net Operating Loss EffectiveIncomeTaxReconciliationEffectOfNetOperatingLoss	-0.21
CY2017Q4	bkyi	Factored Accounts Receivable Factored Amount FactoredAccountsReceivableFactoredAmount	313484
CY2018Q4	bkyi	Factored Accounts Receivable Original Invoice Value FactoredAccountsReceivableOriginalInvoiceValue	221120
CY2017Q4	bkyi	Factored Accounts Receivable Original Invoice Value FactoredAccountsReceivableOriginalInvoiceValue	423349
CY2018	bkyi	Factoring Arrangement Minimum Amount Of Accounts Receivable Per Quarter FactoringArrangementMinimumAmountOfAccountsReceivablePerQuarter	150000
CY2018	bkyi	Factoring Fees FactoringFees	186845
CY2017	bkyi	Factoring Fees FactoringFees	224142
CY2018	bkyi	Increase Decrease In Capitalized Contract Costs IncreaseDecreaseInCapitalizedContractCosts	202353
CY2017	bkyi	Increase Decrease In Capitalized Contract Costs IncreaseDecreaseInCapitalizedContractCosts
CY2018	bkyi	Increase Decrease In Software License Rights IncreaseDecreaseInSoftwareLicenseRights	-1144961
CY2017	bkyi	Increase Decrease In Software License Rights IncreaseDecreaseInSoftwareLicenseRights	-74552
CY2017Q3	bkyi	Maximum Ownership As A Result Of Conversion MaximumOwnershipAsAResultOfConversion	0.0999
CY2017Q4	bkyi	Maximum Ownership As A Result Of Conversion MaximumOwnershipAsAResultOfConversion	0.35
CY2018	bkyi	Operational Costs Per Month OperationalCostsPerMonth	537000
CY2018	bkyi	Percentage Of Remaining Balance Owned Reserved PercentageOfRemainingBalanceOwnedReserved	1
CY2017	bkyi	Percentage Of Remaining Balance Owned Reserved PercentageOfRemainingBalanceOwnedReserved	0.58
	bkyi	Percentage Of Remaining Balance Owned Reserved PercentageOfRemainingBalanceOwnedReserved	0.58
CY2018Q4	bkyi	Software License Rights SoftwareLicenseRights	7915610
CY2017Q4	bkyi	Software License Rights SoftwareLicenseRights	10573808
CY2018Q4	bkyi	Software License Rights Current SoftwareLicenseRightsCurrent	1125000
CY2017Q4	bkyi	Software License Rights Current SoftwareLicenseRightsCurrent	2640000
CY2018Q4	bkyi	Software License Rights Noncurrent SoftwareLicenseRightsNoncurrent	6790610
CY2017Q4	bkyi	Software License Rights Noncurrent SoftwareLicenseRightsNoncurrent	7933808
CY2018	bkyi	Stock Based Fees To Directors And Consultants StockBasedFeesToDirectorsAndConsultants	37532
CY2017	bkyi	Stock Based Fees To Directors And Consultants StockBasedFeesToDirectorsAndConsultants	32030
CY2018	bkyi	Stock Issued Commitment Fee StockIssuedCommitmentFee
CY2017	bkyi	Stock Issued Commitment Fee StockIssuedCommitmentFee	198000
CY2018	bkyi	Stock Issued Consulting Services StockIssuedConsultingServices
CY2017	bkyi	Stock Issued Consulting Services StockIssuedConsultingServices	244084
CY2017	bkyi	Total Warrants Exercised TotalWarrantsExercised
CY2018	bkyi	Total Warrants Exercised TotalWarrantsExercised
CY2017	bkyi	Total Warrants Expired TotalWarrantsExpired
CY2018	bkyi	Total Warrants Expired TotalWarrantsExpired	145841
CY2017	bkyi	Total Warrants Forfeited TotalWarrantsForfeited
CY2018	bkyi	Total Warrants Forfeited TotalWarrantsForfeited
CY2018Q4	bkyi	Warrants Exercisable WarrantsExercisable	3780976
CY2018Q4	bkyi	Warrants Exercisable Weighted Average Exercise Price WarrantsExercisableWeightedAverageExercisePrice	1.59
CY2018	bkyi	Warrants Exercisable Weighted Average Remaining Life WarrantsExercisableWeightedAverageRemainingLife	P2Y18D
CY2016Q4	bkyi	Warrants Outstanding Exercise Price WarrantsOutstandingExercisePrice	3.84
CY2017Q4	bkyi	Warrants Outstanding Exercise Price WarrantsOutstandingExercisePrice	3.81
CY2018Q4	bkyi	Warrants Outstanding Exercise Price WarrantsOutstandingExercisePrice	1.59
CY2016	bkyi	Warrants Outstanding Weighted Average Remaining Life WarrantsOutstandingWeightedAverageRemainingLife	P2Y284D
CY2017	bkyi	Warrants Outstanding Weighted Average Remaining Life WarrantsOutstandingWeightedAverageRemainingLife	P2Y21D
CY2018	bkyi	Warrants Outstanding Weighted Average Remaining Life WarrantsOutstandingWeightedAverageRemainingLife	P2Y18D
CY2018Q4	bkyi	Warrants Vested Or Expected To Vest WarrantsVestedOrExpectedToVest	3780976
CY2018Q4	bkyi	Warrants Vested Or Expected To Vest Weighted Average Exercise Price WarrantsVestedOrExpectedToVestWeightedAverageExercisePrice	1.59
CY2018	bkyi	Warrants Vested Or Expected To Vest Weighted Average Remaining Life WarrantsVestedOrExpectedToVestWeightedAverageRemainingLife	P2Y18D
CY2018	bkyi	Weighted Average Exercise Price Warrant Increase Due To Trigger Of Antidilution Provision Feature WeightedAverageExercisePriceWarrantIncreaseDueToTriggerOfAntidilutionProvisionFeature	1.50
CY2017	bkyi	Weighted Average Exercise Price Warrants Exercised WeightedAverageExercisePriceWarrantsExercised
CY2018	bkyi	Weighted Average Exercise Price Warrants Exercised WeightedAverageExercisePriceWarrantsExercised
CY2017	bkyi	Weighted Average Exercise Price Warrants Expired WeightedAverageExercisePriceWarrantsExpired
CY2018	bkyi	Weighted Average Exercise Price Warrants Expired WeightedAverageExercisePriceWarrantsExpired	6
CY2017	bkyi	Weighted Average Exercise Price Warrants Forfeited WeightedAverageExercisePriceWarrantsForfeited
CY2018	bkyi	Weighted Average Exercise Price Warrants Forfeited WeightedAverageExercisePriceWarrantsForfeited
CY2017	bkyi	Weighted Average Exercise Price Warrants Granted WeightedAverageExercisePriceWarrantsGranted	3.60
CY2018	bkyi	Weighted Average Exercise Price Warrants Granted WeightedAverageExercisePriceWarrantsGranted	1.50
CY2018	dei	Amendment Flag AmendmentFlag	false
CY2018	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2018	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2018
CY2018	dei	Document Period End Date DocumentPeriodEndDate	2018-12-31
CY2018	dei	Document Type DocumentType	10-K
CY2019Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	13991688
CY2018	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2018Q2	dei	Entity Public Float EntityPublicFloat	25200000
CY2018	dei	Entity Shell Company EntityShellCompany	false
CY2018	dei	Entity Small Business EntitySmallBusiness	true
CY2018Q4	us-gaap	Accounts And Other Receivables Net Current AccountsAndOtherReceivablesNetCurrent	56682
CY2017Q4	us-gaap	Accounts And Other Receivables Net Current AccountsAndOtherReceivablesNetCurrent	109865
CY2018Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	481269
CY2017Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	499230
CY2018Q4	us-gaap	Accounts Receivable Gross AccountsReceivableGross	3307817
CY2017Q4	us-gaap	Accounts Receivable Gross AccountsReceivableGross	4649731
CY2018Q4	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	1587817
CY2017Q4	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	2889731
CY2018Q4	us-gaap	Accounts Receivable Gross Noncurrent AccountsReceivableGrossNoncurrent	1720000
CY2017Q4	us-gaap	Accounts Receivable Gross Noncurrent AccountsReceivableGrossNoncurrent	1760000
CY2018Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	1574032
CY2017Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	3635946
CY2018Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1574032
CY2017Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2875946
CY2018Q4	us-gaap	Accounts Receivable Net Noncurrent AccountsReceivableNetNoncurrent
CY2017Q4	us-gaap	Accounts Receivable Net Noncurrent AccountsReceivableNetNoncurrent	760000
CY2018Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	548232
CY2017Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	688023
CY2018Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	77133
CY2017Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	85633
CY2018Q4	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	224135
CY2017Q4	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	341884
CY2018Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	690452
CY2017Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	605835
CY2018Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	85599140
CY2017Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	80829001
CY2017	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	498654
CY2018	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	942692
CY2017	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	80366
CY2018	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	338845
CY2018	us-gaap	Advertising Expense AdvertisingExpense	309000
CY2017	us-gaap	Advertising Expense AdvertisingExpense	386000
CY2018	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	980224
CY2017	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	972764
CY2018Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	1733785
CY2017Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	1013785
CY2018Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	13785
CY2017Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	13785
CY2018Q4	us-gaap	Allowance For Doubtful Accounts Receivable Noncurrent AllowanceForDoubtfulAccountsReceivableNoncurrent	1720000
CY2017Q4	us-gaap	Allowance For Doubtful Accounts Receivable Noncurrent AllowanceForDoubtfulAccountsReceivableNoncurrent	1000000
CY2018	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	15596
CY2017	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	13726
CY2018	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0
CY2017	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0
CY2018Q4	us-gaap	Assets Assets	11692332
CY2017Q4	us-gaap	Assets Assets	16078822
CY2018Q1	us-gaap	Assets Assets	16318839
CY2018Q4	us-gaap	Assets Current AssetsCurrent	4229297
CY2017Q4	us-gaap	Assets Current AssetsCurrent	7014033
CY2018Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	7463035
CY2017Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	9064789
CY2018	us-gaap	Capitalized Contract Cost Amortization CapitalizedContractCostAmortization	123171
CY2017	us-gaap	Capitalized Contract Cost Amortization CapitalizedContractCostAmortization
CY2018Q4	us-gaap	Capitalized Contract Cost Amortization Period CapitalizedContractCostAmortizationPeriod	P4Y
CY2017Q4	us-gaap	Capitalized Contract Cost Net CapitalizedContractCostNet
CY2018Q1	us-gaap	Capitalized Contract Cost Net CapitalizedContractCostNet	240017
CY2018Q4	us-gaap	Capitalized Contract Cost Net CapitalizedContractCostNet	319199
CY2018Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	323943
CY2017Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	288721
CY2016Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1061307
CY2018	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	35222
CY2017	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-772586
CY2018Q4	us-gaap	Cash Uninsured Amount CashUninsuredAmount	0
CY2017Q4	us-gaap	Cash Uninsured Amount CashUninsuredAmount	0
CY2015Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	3.60
CY2016Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	1260080
CY2017Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	1398969
CY2018Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	3780976
CY2018Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2017Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2018Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2017Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2018Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	170000000
CY2017Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	170000000
CY2018Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	13972158
CY2017Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	7691324
CY2018Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	13972158
CY2017Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	7691324
CY2018Q4	us-gaap	Common Stock Value CommonStockValue	1398
CY2017Q4	us-gaap	Common Stock Value CommonStockValue	769
CY2018Q4	us-gaap	Compensated Absences Liability CompensatedAbsencesLiability	154169
CY2017Q4	us-gaap	Compensated Absences Liability CompensatedAbsencesLiability	164132
CY2018Q4	us-gaap	Contract With Customer Asset Net Noncurrent ContractWithCustomerAssetNetNoncurrent	319199
CY2018Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	196609
CY2017Q4	us-gaap	Contract With Customer Asset Net Noncurrent ContractWithCustomerAssetNetNoncurrent
CY2017Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	507866
CY2018Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	196609
CY2017Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	507866
CY2018	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	382000
CY2017	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	0
CY2018	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	4164190
CY2017	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	3242151
CY2018Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	50000
CY2017Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	46000
CY2018Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	12735000
CY2017Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	12052000
CY2018Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits	91000
CY2017Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits	118000
CY2018Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	644000
CY2017Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	387000
CY2018Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	474000
CY2017Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	277000
CY2018Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	13981000
CY2017Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	12862000
CY2018Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	13000
CY2017Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	18000
CY2017	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	0
CY2018	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	0
CY2018Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	8712
CY2017Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	8712
CY2018	us-gaap	Depreciation Depreciation	84617
CY2017	us-gaap	Depreciation Depreciation	52709
CY2018Q4	us-gaap	Dividends Payable Current DividendsPayableCurrent
CY2017Q4	us-gaap	Dividends Payable Current DividendsPayableCurrent	630408
CY2017	us-gaap	Dividends Preferred Stock Stock DividendsPreferredStockStock	769158
CY2018	us-gaap	Dividends Preferred Stock Stock DividendsPreferredStockStock	198033
CY2018	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.73
CY2017	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.76
CY2018	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations
CY2017	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations
CY2017	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.34
CY2018	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21
CY2018	us-gaap	Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
CY2017	us-gaap	Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate	-0.13
CY2018	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P1Y182D
CY2018Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	1228771
CY2018Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	182438
CY2017Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	166842
CY2018Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	131000
CY2018Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	13000
CY2018Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	13000
CY2018Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	13000
CY2018Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	13000
CY2018Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	13000
CY2018Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	378344
CY2017Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	347946
CY2018Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	195906
CY2017Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	181104
CY2018	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	80
CY2017	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	27
CY2018	us-gaap	Gross Profit GrossProfit	-119648
CY2017	us-gaap	Gross Profit GrossProfit	3060833
CY2018	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0
CY2017	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0
CY2018	us-gaap	Income Taxes Paid IncomeTaxesPaid
CY2017	us-gaap	Income Taxes Paid IncomeTaxesPaid
CY2018	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-17961
CY2017	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	32388
CY2018	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-1341914
CY2017	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	1002700
CY2018	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-139793
CY2017	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	352700
CY2018	us-gaap	Increase Decrease In Contract With Customer Asset IncreaseDecreaseInContractWithCustomerAsset	79182
CY2018	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-311257
CY2017	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-125196
CY2018	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	51982
CY2017	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	481419
CY2018	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	-53183
CY2017	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	56227
CY2018	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-1843
CY2017	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	33472
CY2018Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	195906
CY2017Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	181104
CY2018	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	80
CY2017	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	27
CY2018	us-gaap	Interest Paid Net InterestPaidNet
CY2017	us-gaap	Interest Paid Net InterestPaidNet
CY2018Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	496358
CY2017Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	487858
CY2018Q4	us-gaap	Inventory Net InventoryNet	998829
CY2017Q4	us-gaap	Inventory Net InventoryNet	946847
CY2018Q4	us-gaap	Inventory Raw Materials And Supplies Net Of Reserves InventoryRawMaterialsAndSuppliesNetOfReserves	502471
CY2017Q4	us-gaap	Inventory Raw Materials And Supplies Net Of Reserves InventoryRawMaterialsAndSuppliesNetOfReserves	458989
CY2018Q4	us-gaap	Liabilities Liabilities	1226110
CY2017Q4	us-gaap	Liabilities Liabilities	2325527
CY2018Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	11692332
CY2017Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	16078822
CY2018Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	16318839
CY2018Q4	us-gaap	Liabilities Current LiabilitiesCurrent	1226110
CY2017Q4	us-gaap	Liabilities Current LiabilitiesCurrent	2325527
CY2018	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1731155
CY2017	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1919634
CY2018	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-82458
CY2017	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-226758
CY2018	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1613475
CY2017	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2465462
CY2018	us-gaap	Net Income Loss NetIncomeLoss	-6868875
CY2017	us-gaap	Net Income Loss NetIncomeLoss	-4275338
CY2018	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-8495874
CY2017	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-5044496
CY2018	us-gaap	Operating Expenses OperatingExpenses	6749307
CY2017	us-gaap	Operating Expenses OperatingExpenses	7336198
CY2018	us-gaap	Operating Income Loss OperatingIncomeLoss	-6868955
CY2017	us-gaap	Operating Income Loss OperatingIncomeLoss	-4275365
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	695000
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Due Current OperatingLeasesFutureMinimumPaymentsDueCurrent	192000
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Due In Five Years OperatingLeasesFutureMinimumPaymentsDueInFiveYears	89000
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	131000
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	127000
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	156000
CY2018Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	64359
CY2017Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	58403
CY2018Q4	us-gaap	Other Assets Current OtherAssetsCurrent	56682
CY2017Q4	us-gaap	Other Assets Current OtherAssetsCurrent	109865
CY2018	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	143945
CY2017	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	80366
CY2018	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	30398
CY2017	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	60698
CY2018	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	52060
CY2017	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	166060
CY2018	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	198033
CY2017	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	769158
CY2018Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2018Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000
CY2018Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	150811
CY2017Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	152654
CY2018	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	1875100
CY2017	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	2000000
CY2018Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	839060
CY2017Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	787000
CY2018Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	148608
CY2017Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	181165
CY2018	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	720000
CY2017	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	500000
CY2018	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1415401
CY2017	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1659875
CY2018Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-75134316
CY2017Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-67076492
CY2018Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-66836475
CY2018	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	4044542
CY2017	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	6302984
CY2018Q4	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	9436
CY2017Q4	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	5614
CY2018	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	5333906
CY2017	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	5676323
CY2018	us-gaap	Share Based Compensation ShareBasedCompensation	942692
CY2017	us-gaap	Share Based Compensation ShareBasedCompensation	940734
CY2018	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2017	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2018	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	1.43
CY2017	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	1.38
CY2018	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.027
CY2017	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0192
CY2018Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	3.17
CY2018	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	0
CY2017	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	5667
CY2018	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	351918
CY2017	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	1234167
CY2018	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	1.53
CY2017	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	2.32
CY2017Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	0
CY2018Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	0
CY2016Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	3.99
CY2017Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	2.91
CY2018Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	2.72
CY2018Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	0
CY2018Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	2.79
CY2017	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	2.16
CY2018	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2017	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	8.86
CY2018	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	3.03
CY2017	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	2.62
CY2018	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	2.63
CY2017	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	2.69
CY2018	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	1.97
CY2018Q4	us-gaap	Share Price SharePrice	0.75
CY2018	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P4Y182D
CY2017	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P4Y186D
CY2018Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	0
CY2018	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P3Y343D
CY2017	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P5Y233D
CY2018	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P5Y
CY2018	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P4Y302D
CY2017	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	946435
CY2016	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	197281
CY2018Q1	us-gaap	Stock Issued During Period Shares Conversion Of Convertible Securities StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities	1794190
CY2017Q3	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	90000
CY2017	us-gaap	Stock Issued During Period Shares Share Based Compensation StockIssuedDuringPeriodSharesShareBasedCompensation	1610
CY2018	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0
CY2017	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	4167
CY2017	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	354585
CY2017	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	2000000
CY2018	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	2070000
CY2017	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	32030
CY2018	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	37532
CY2018Q4	us-gaap	Stockholders Equity StockholdersEquity	10466222
CY2017Q4	us-gaap	Stockholders Equity StockholdersEquity	13753295
CY2016Q4	us-gaap	Stockholders Equity StockholdersEquity	15452888
CY2018Q1	us-gaap	Stockholders Equity StockholdersEquity	13993312
CY2018Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	0
CY2017Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	0
CY2018	us-gaap	Use Of Estimates UseOfEstimates	<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; text-align: left; margin: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2.</div> <div style="display: inline; font-style: italic;">Use of Estimates</div></div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; text-align: left; margin: 0pt;"> </div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; text-align: justify; margin: 0pt; text-indent: 18pt;">Our consolidated financial statements are prepared in accordance with GAAP as set forth in the Financial Accounting Standards Board’s (FASB) Accounting Standards Codification (ASC) and consider the various staff accounting bulletins and other applicable guidance issued by the U.S. Securities and Exchange Commission (SEC). These accounting principles require us to make certain estimates, judgments and assumptions. The Company believes that the estimates, judgments and assumptions upon which it relies are reasonable based upon information available to us at the time that these estimates, judgments and assumptions are made. These estimates, judgments and assumptions can affect the reported amounts of assets and liabilities as of the date of the financial statements as well as the reported amounts of revenues and expenses during the periods presented. To the extent there are material differences between these estimates, judgments or assumptions and actual results, its consolidated financial statements will be affected. In many cases, the accounting treatment of a particular transaction is specifically dictated by GAAP and does <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> require management’s judgment in its application. There are also areas in which management’s judgment in selecting among available alternatives would <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> produce a materially different result.</div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; text-align: justify; margin: 0pt;"></div></div></div></div></div></div></div>
CY2018	us-gaap	Warrant Down Round Feature Increase Decrease In Equity Amount WarrantDownRoundFeatureIncreaseDecreaseInEquityAmount	1428966
CY2017	us-gaap	Warrant Down Round Feature Increase Decrease In Equity Amount WarrantDownRoundFeatureIncreaseDecreaseInEquityAmount
CY2018	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	11607933
CY2017	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	6638382

Files In Submission

Name	View Source	Status
0001437749-19-006258-index-headers.html	Edgar Link	pending
0001437749-19-006258-index.html	Edgar Link	pending
0001437749-19-006258.txt	Edgar Link	pending
0001437749-19-006258-xbrl.zip	Edgar Link	pending
bkyi-20181231.xml	Edgar Link	completed
bkyi-20181231.xsd	Edgar Link	pending
bkyi-20181231_cal.xml	Edgar Link	unprocessable
bkyi-20181231_def.xml	Edgar Link	unprocessable
bkyi-20181231_lab.xml	Edgar Link	unprocessable
bkyi-20181231_pre.xml	Edgar Link	unprocessable
bkyi20181231_10k.htm	Edgar Link	pending
ex_139113.htm	Edgar Link	pending
ex_139113img001.jpg	Edgar Link	pending
ex_139114.htm	Edgar Link	pending
ex_139115.htm	Edgar Link	pending
ex_139116.htm	Edgar Link	pending
ex_139117.htm	Edgar Link	pending
ex_139440.htm	Edgar Link	pending
ex_139441.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$BKYI
BIO KEY INTERNATIONAL INC Stock $bkyi

2019 Q1 Form 10-K Financial Statement

#000143774919006258 Filed on April 01, 2019

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BKYI BIO KEY INTERNATIONAL INC Stock $bkyi

2019 Q1 Form 10-K Financial Statement

#000143774919006258 Filed on April 01, 2019

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BKYI
BIO KEY INTERNATIONAL INC Stock $bkyi